US$ 23.90
tirzepatide and autoimmune disorders GLP-1 Drugs: Ozempic, Mounjaro, Zepbound: A Promising Treatment for Diseases? The Exhilirating Movement From Treatment
Description
1 of 3 Gone are the days of one-size-fits-all weight loss plans

Effective Practice and Organisation of Care (EPOC) (2015) EPOC taxonomy

Why you should avoid it Increased nausea and reflux Risk of hypoglycemia Empty calories with no nutritional value Easy swaps Mocktails Seltzer with lime and herbs Kombucha (unsweetened or low sugar) If you choose to drink alcohol keep it minimal and never on an empty stomach

10.3389/fneur.2024.1321058 93 WatersM

Novo Nordisk faces a product liability lawsuit over the risk of gastroparesis from Ozempic, alleging that the drug maker has failed to warn that users may be left with severe and permanent stomach problems, including vomiting, diarrhea, acid reflux and other long-term gastric side effects

LBA 39 Funck, K
